DE60209511T2 - Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten - Google Patents

Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten Download PDF

Info

Publication number
DE60209511T2
DE60209511T2 DE60209511T DE60209511T DE60209511T2 DE 60209511 T2 DE60209511 T2 DE 60209511T2 DE 60209511 T DE60209511 T DE 60209511T DE 60209511 T DE60209511 T DE 60209511T DE 60209511 T2 DE60209511 T2 DE 60209511T2
Authority
DE
Germany
Prior art keywords
xylometazoline
salt
ipratropium
composition
nasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60209511T
Other languages
German (de)
English (en)
Other versions
DE60209511D1 (de
Inventor
Anette Hanne MOESGAARD
Lowenstein Karin CHRISTENSEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharma AS
Original Assignee
Nycomed Danmark AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark AS filed Critical Nycomed Danmark AS
Publication of DE60209511D1 publication Critical patent/DE60209511D1/de
Application granted granted Critical
Publication of DE60209511T2 publication Critical patent/DE60209511T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Polyurethanes Or Polyureas (AREA)
DE60209511T 2001-09-18 2002-09-18 Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten Expired - Lifetime DE60209511T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200101356 2001-09-18
DK200101356 2001-09-18
PCT/IB2002/003828 WO2003024433A2 (en) 2001-09-18 2002-09-18 Compositions for treatment of common cold, comprising ipratropium and xylometazoline

Publications (2)

Publication Number Publication Date
DE60209511D1 DE60209511D1 (de) 2006-04-27
DE60209511T2 true DE60209511T2 (de) 2006-10-05

Family

ID=8160714

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60209511T Expired - Lifetime DE60209511T2 (de) 2001-09-18 2002-09-18 Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten

Country Status (20)

Country Link
US (2) US7652030B2 (enExample)
EP (2) EP1661570A3 (enExample)
JP (1) JP4500045B2 (enExample)
KR (1) KR100810872B1 (enExample)
CN (1) CN1290502C (enExample)
AT (1) ATE318601T1 (enExample)
BR (1) BRPI0212586B8 (enExample)
CA (1) CA2460140C (enExample)
DE (1) DE60209511T2 (enExample)
DK (1) DK1446119T3 (enExample)
EA (1) EA008165B1 (enExample)
ES (1) ES2259098T3 (enExample)
HU (1) HU226527B1 (enExample)
MX (1) MXPA04002500A (enExample)
NO (1) NO334441B1 (enExample)
NZ (1) NZ531792A (enExample)
PL (1) PL208686B1 (enExample)
PT (1) PT1446119E (enExample)
SI (1) SI1446119T1 (enExample)
WO (1) WO2003024433A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
PL208686B1 (pl) * 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1713472A2 (en) * 2004-02-06 2006-10-25 MEDA Pharma GmbH & Co. KG Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
WO2005084330A2 (en) * 2004-03-02 2005-09-15 Synergia Pharma, Inc. Compositions and methods for treating nasal congestion
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
KR100866720B1 (ko) * 2004-12-27 2008-11-05 에자이 알앤드디 매니지먼트 가부시키가이샤 항치매 약물의 안정화 방법
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US20090270472A1 (en) * 2008-04-25 2009-10-29 Kenneth Gould Method to use oxymetazoline to interrupt the development of the common cold syndrome
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
AP3141A (en) 2009-11-25 2015-02-28 Boehringer Ingelheim Int Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP2978407B1 (en) * 2013-03-29 2020-05-06 Santa Farma Ilaç Sanayi A.S. Aqueous solution composition containing ipratropium and oxymetazoline
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
DK3139979T3 (da) 2014-05-07 2023-10-09 Boehringer Ingelheim Int Enhed, forstøver og fremgangsmåde
EP3139984B1 (en) 2014-05-07 2021-04-28 Boehringer Ingelheim International GmbH Nebulizer
CN106456913B (zh) 2014-05-07 2019-08-30 勃林格殷格翰国际有限公司 喷雾器和容器
EA032719B1 (ru) * 2014-12-24 2019-07-31 Ярдан-Галенски Лабораторий Д.Д. Назальная лекарственная форма против заложенности носа
MX383771B (es) * 2015-12-02 2025-03-14 Pablo Cortes Borrego Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos.
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08508007A (ja) 1991-11-19 1996-08-27 センター フォー イノベイティブ テクノロジー ウィルス抑止性抗両受体によるかぜの複合治療法
IL101056A (en) 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9218834D0 (en) 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
WO1994013263A1 (en) 1992-12-09 1994-06-23 Jager Paul D Stabilized medicinal aerosol solution formulations
EP0780127A1 (en) 1995-12-19 1997-06-25 The Procter & Gamble Company A nasal spray containing a steroid and a antihistamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
IL131492A0 (en) * 1997-04-30 2001-01-28 Warner Lambert Co Topical nasal antiinflammatory compositions
PT1051155E (pt) * 1998-01-30 2002-10-31 Novartis Consumer Health Sa Solucoes nasais
EP1087750B1 (en) 1998-06-18 2003-11-12 Boehringer Ingelheim Pharmaceuticals Inc. Pharmaceutical formulations for aerosols with two or more active substances
PT1194145E (pt) 1999-06-22 2003-06-30 Boehringer Ingelheim Int Solucao estavel de xilometazolina e de oximetazolina
PL208686B1 (pl) * 2001-09-18 2011-05-31 Nycomed Danmark Aps Kompozycja w postaci roztworu wodnego do leczenia przeziębienia oraz zastosowanie połączenia ipratropium lub jego soli i ksylometazoliny lub jej soli

Also Published As

Publication number Publication date
EP1661570A2 (en) 2006-05-31
JP4500045B2 (ja) 2010-07-14
CA2460140A1 (en) 2003-03-27
CN1290502C (zh) 2006-12-20
DE60209511D1 (de) 2006-04-27
JP2005505569A (ja) 2005-02-24
PT1446119E (pt) 2006-07-31
PL370536A1 (en) 2005-05-30
HUP0402075A2 (hu) 2005-02-28
EP1661570A3 (en) 2012-10-24
PL208686B1 (pl) 2011-05-31
SI1446119T1 (sl) 2006-08-31
CA2460140C (en) 2009-09-01
DK1446119T3 (da) 2006-07-10
NO334441B1 (no) 2014-03-03
US20100093783A1 (en) 2010-04-15
BR0212586A (pt) 2004-10-13
HU226527B1 (hu) 2009-03-30
CN1555263A (zh) 2004-12-15
EA008165B1 (ru) 2007-04-27
NZ531792A (en) 2006-02-24
KR100810872B1 (ko) 2008-03-06
ES2259098T3 (es) 2006-09-16
EP1446119A2 (en) 2004-08-18
ATE318601T1 (de) 2006-03-15
BR0212586B1 (pt) 2013-11-19
MXPA04002500A (es) 2004-11-22
WO2003024433A2 (en) 2003-03-27
EP1446119B1 (en) 2006-03-01
HK1067984A1 (en) 2005-04-22
US7652030B2 (en) 2010-01-26
EA200400444A1 (ru) 2005-02-24
US8450339B2 (en) 2013-05-28
KR20040049849A (ko) 2004-06-12
NO20041070L (no) 2004-05-18
BRPI0212586B8 (pt) 2021-05-25
HUP0402075A3 (en) 2008-04-28
WO2003024433A3 (en) 2004-06-10
US20040248924A1 (en) 2004-12-09

Similar Documents

Publication Publication Date Title
DE60209511T2 (de) Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
DE69024672T2 (de) Sprays zur Behandlung von Infektionen des Tractus Respiratorius
DE60133203T3 (de) Fentanyl Zusammensetzung für nasale Anwendung
DE69108200T2 (de) 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indol-5-methansulfonamid Sulfat (2:1).
AT16553U1 (de) Intranasale pharmazeutische Darreichungsformen umfassend Naloxon
EP1265615A2 (de) Neue kombination nichtsedierender antihistaminika mit substanzen, die die leukotrienwirkung beeinflussen, zur behandlung der rhinitis/konjunktivitis
EP0125634A1 (de) Verwendung einer sekretolytisch wirkenden Substanz zur Herstellung eines Antischnarchmittels und zur Bekämpfung des Schnarchphänomens
DE69411726T2 (de) Zusammensetzungen zur freigabe einer aromatischen substanz in die nase
EP2200603B1 (de) Osmolyte zur behandlung von allergisch bedingten atemwegserkrankungen
EP2050435B1 (de) Hustenpräparat
DE19519056A1 (de) Verwendung von Antidepressiva zur Behandlung von Asthma und/oder Atemwegserkrankungen mittels inhalatorischer Applikation
CH662734A5 (de) Antischnarchmittel.
EP0240907B1 (de) Verwendung von trans-4-[(2-Amino-3,5-dibrom-benzyl)-amino]cyclohexanol
DE60023341T2 (de) Orale lösung enthaltend galanthamine und ein süssungsmittel
DE60220825T2 (de) Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks
EP2818167A1 (de) Antiviral wirksame pharmazeutische Zusammensetzung
EP4349333B1 (de) Verwendung von aminopyridin, insbesondere amifampridin, bei der behandlung einer viral assoziierten fatigue
DD291924A5 (de) Verfahren zur herstellung einer waessrigen loesung eines pentamidinsalzes
AU2002329578B2 (en) Compositions for treatment of common cold
AU2002329578A1 (en) Compositions for treatment of common cold
HK1067984B (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold
HK1092064A (en) Compositions comprising ipatropium and xylometazoline for treatment of the common cold

Legal Events

Date Code Title Description
8364 No opposition during term of opposition